DOCTOR’S NOTE
Advanced prostate cancer patients could live longer if given a new mix of therapies, a study suggests.
Hormone treatments are normally used to fight the most common form of cancer among UK men.
But a world-first trial showed this option alongside two forms of radiotherapy slowed the growth of the disease once it had spread to bones.
The research was led by Prof Joe O’Sullivan, of Queen’s University Belfast.
He said: “The approach may prove more effective than existing hormone treatment in targeting prostate cancer cells.”
More than 47,500 men in Britain are diagnosed with the disease every year – 129 every day.